Passa al contenuto
Merck
Tutte le immagini(1)

Documenti fondamentali

C6643

Sigma-Aldrich

Clofibrate

liquid

Sinonimo/i:

2-(4-Chlorophenoxy)-2-methylpropionic acid ethyl ester, Ethyl 2-(4-chlorophenoxy)-2-methylpropionate, Ethyl 2-(4-chlorophenoxy)isobutyrate

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali

Scegli un formato

250 MG
CHF 58.80
1 G
CHF 66.50
5 G
CHF 276.00
10 G
CHF 499.00

CHF 58.80


Spedizione prevista il30 maggio 2025


Richiedi un ordine bulk

Scegli un formato

Cambia visualizzazione
250 MG
CHF 58.80
1 G
CHF 66.50
5 G
CHF 276.00
10 G
CHF 499.00

About This Item

Formula empirica (notazione di Hill):
C12H15ClO3
Numero CAS:
Peso molecolare:
242.70
Beilstein:
1913459
Numero CE:
Numero MDL:
Codice UNSPSC:
12352200
ID PubChem:
NACRES:
NA.77

CHF 58.80


Spedizione prevista il30 maggio 2025


Richiedi un ordine bulk

Stato

liquid

Colore

clear colorless

Densità

1.14 g/mL at 25 °C (lit.)

Ideatore

Wyeth

Temperatura di conservazione

2-8°C

Stringa SMILE

CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1

InChI

1S/C12H15ClO3/c1-4-15-11(14)12(2,3)16-10-7-5-9(13)6-8-10/h5-8H,4H2,1-3H3
KNHUKKLJHYUCFP-UHFFFAOYSA-N

Informazioni sul gene

human ... PPARA(5465)
mouse ... Ppara(19013)

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Applicazioni

Clofibrate has been used:
  • as a quinolinate phosphoribosyltransferase (QPRT) agonist to study its effects on hepatitis C virus (HCV) infection[1]
  • as peroxisome proliferated activated receptor (PPAR) agonist to study its effects on autophagy in rat liver cells[2]
  • as a hepatotoxicant to study its effects on gene expression in primary rat hepatocytes[3]

Azioni biochim/fisiol

Clofibrate is a peroxisome proliferated activated receptor α (PPARα) agonist.[4] It is a fibric acid derivative and has a therapeutic effect on hypertriglyceridemia and hyperlipoproteinemia type III. Clofibrate participates in lowering the very-low-density lipoprotein (VLDL) and cholesterol levels in hyperlipoproteinemia type III patients. It facilitates the decrease of total serum bilirubin concentration in Gilbert′s syndrome.[5]

Caratteristiche e vantaggi

This compound is featured on the Nuclear Receptors (PPARs) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
This compound was developed by Wyeth. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Confezionamento

Bottomless glass bottle. Contents are inside inserted fused cone.

Pittogrammi

CorrosionExclamation mark

Avvertenze

Danger

Indicazioni di pericolo

Classi di pericolo

Acute Tox. 4 Oral - Eye Dam. 1 - Skin Irrit. 2 - STOT SE 3

Organi bersaglio

Respiratory system

Codice della classe di stoccaggio

10 - Combustible liquids

Classe di pericolosità dell'acqua (WGK)

WGK 3

Punto d’infiammabilità (°F)

235.4 °F - closed cup

Punto d’infiammabilità (°C)

113 °C - closed cup

Dispositivi di protezione individuale

Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter


Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

Non trovi la versione di tuo interesse?

Se hai bisogno di una versione specifica, puoi cercare il certificato tramite il numero di lotto.

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

I clienti hanno visto anche

Slide 1 of 7

1 of 7

4,4′-DDT solution certified reference material, 5000 μg/mL in methanol

Supelco

40124

4,4′-DDT solution

Cimetidine

Sigma-Aldrich

C4522

Cimetidine

Tolbutamide analytical standard

Supelco

T0891

Tolbutamide

AICAR ≥98% (HPLC), powder

Sigma-Aldrich

A9978

AICAR

K Nadira De Abrew et al.
Toxicology, 328, 29-39 (2014-12-06)
High-content data have the potential to inform mechanism of action for toxicants. However, most data to support this notion have been generated in vivo. Because many cell lines and primary cells maintain a differentiated cell phenotype, it is possible that
Drug treatment of lipid disorders.
R H Knopp
The New England journal of medicine, 341(7), 498-511 (1999-08-12)
Szu-Han Chen et al.
PloS one, 12(11), e0187507-e0187507 (2017-11-03)
We tested the hypothesis that prenatal administration of PPARα agonist clofibrate may permanently increase browning capacity of developing white adipose tissue (WAT). Pregnant C57BL/6J mice were fed a basal diet, without (C) or with 0.5% clofibrate (CF, a PPARα agonist)
Masayuki Yoshikawa et al.
Journal of natural products, 68(9), 1360-1365 (2005-09-27)
The methanolic extract and its n-butanol-soluble fraction from the flowers of the tea plant (Camellia sinensis) were found to suppress serum triglyceride elevation in olive oil-treated mice. From the n-butanol-soluble fraction, three new acylated oleanane-type triterpene oligoglycosides, floratheasaponins A-C (1-3)
Sara Chuang et al.
Journal of medicinal chemistry, 52(17), 5344-5355 (2009-08-12)
Liver-fatty acid binding protein (L-FABP) is found in high levels in enterocytes and is involved in cytosolic solubilization of fatty acids. In addition, L-FABP has been shown to bind endogenous and exogenous lipophilic compounds, suggesting that it may also play

Articoli

Cholesterol synthesis regulation by dietary levels, LDL receptors control lipid-rich LDL particle transport in cells.

Discover Bioactive Small Molecules for Lipid Signaling Research

Questions

Reviews

No rating value

Active Filters

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.